Shots:
- Roche’s cobas SARS-CoV-2 test to be use on high-throughput cobas 6800/8800 systems has received the US FDA’s EUA for testing individuals without symptoms or reasons to control the spread of COVID-19
- The authorization expands SARS-CoV-2 testing to include people without symptoms and applies to pooled samples containing up to and including 6 individual samples
- Asymptomatic testing with the cobas SARS-CoV-2 test is available in countries accepting the CE mark
Click here to read full press release/ article | Ref: PRNewswire | Image: Switzerland Global Enterprise
The post Roche Receives the US FDA’s EUA for cobas SARS-CoV-2 Test to Suspect COVID-19 first appeared on PharmaShots.
